-
-
Call more information
660-596-2224 -
Authors: T. Andrew Bowdle, M.D., Ph.D., F.A.S.E. et al Anesthesiology July 2023, Vol. 139, 6–15. Background The dose of sugammadex recommended by the manufacturer for reversal of rocuronium is 2 mg/kg when the train-of-four count is 2 or more and 4 mg/kg when it is less than 2 but there is a posttetanic count of at least 1. […]
Read MoreAuthors: Patrick Forrest, MD et al ASA Monitor July 2023, Vol. 87, 1–5. Many readers may now be familiar with the new ASA practice guidelines for monitoring and antagonism of neuromuscular blockade that were published this past January (Anesthesiology 2023;138:13-41). For those who are not, this article may serve as a brief overview of the advances […]
Read MoreASA Monitor April 2023, Vol. 87, 17. UpToDate® and ASA Monitor are collaborating to present select content abstracts on “What’s New in Anesthesiology.” UpToDate is an evidence-based, clinical support resource used worldwide by health care practitioners to make decisions at the point of care. For complete, current “What’s New” content, or to become a subscriber for full content access, […]
Read MoreASA Monitor July 2023, Vol. 87, 10. A 45-year-old woman is scheduled to undergo a bilateral mastectomy for metastatic breast cancer. According to a recent study of patients undergoing breast cancer surgery with general anesthesia maintained with propofol or volatile agents, which of the following MOST likely describes overall survival with use of propofol compared to […]
Read MoreASA Monitor July 2023, Vol. 87, 7. Which of the following immunosuppressive drugs is MOST likely to cause renal dysfunction? □ (A) Tacrolimus □ (B) Mycophenolate mofetil □ (C) Basiliximab Immunosuppressant drugs are used to prevent or treat allograft rejection. Most of these drugs act during the induction phase of the immunological response, reducing lymphocyte proliferation. Some of them […]
Read MoreAuthors: Judith Jurin Semo, JD; Shena J. Scott, MBA, FACMPE ASA Monitor July 2023, Vol. 87, 17–18. Restrictive covenants or noncompetes in employment are a contentious topic (ASA Monitor 2020;84:1-18). If a proposed rule issued in January 2023 by the Federal Trade Commission (FTC) is adopted, most employers in the United States will be foreclosed from requiring […]
Read MoreAuthor: Zachary Deutch, MD, FASA ASA Monitor July 2023, Vol. 87, 13–15. The answer to the question in the title is rhetorical, as it will be in the eye of the beholder. Each ASA member has his or her own unique practice situation, personal disposition, and life priorities, so the realities one perceives as “bad” might […]
Read MoreAuthor: Mathieu Rees MedicalNewsToday Lung tumors can cause chest pain that worsens when coughing, laughing, or breathing deeply. Chest pain is most likely to develop during the later stages of lung cancer. Lung cancer develops when lung cells begin to grow uncontrollably. Over time, this causes tumors to form within the lungs, sometimes causing chest […]
Read MoreDG Journal Club Authors: Valery Piacherski, Lidziya Muzyka Sci Rep. 2023 Feb 15; 13(1): 2736 Various advantages of isobaric bupivacaine, levobupivacaine, and hyperbaric bupivacaine are described. There are no studies reliably determining the benefits of these forms of bupivacaine. The purpose of the study was to compare the efficacy of spinal anesthesia (SA) performed with […]
Read MoreInfused tympanostomy tubes for treatment of middle ear infections Middle ear infections are extremely common and affect children especially, with 40% developing recurrent infections that can lead to complications like impaired hearing, speech and language delays, perforations in their eardrums, and life-threatening meningitis. “Tympanostomy tubes” (TTs) are surgically inserted into the eardrum to create an […]
Read More